New Neuro Glioblastoma Trial to Open at the Tom Baker Cancer

The Phase I-II Niacin in Neuro Glioblastoma trial is scheduled to open at the Tom Baker Cancer Centre in the Spring of 2021. This trial is based on the University of Calgary researchers' discovery of a new tactic to stop the growth of the deadly brain cancer. Findings indicate the body may be the ultimate weapon against glioblastoma, but it needs help.

 

View Original Article

Archives